CD34 and neoplasm: Due to low numbers of CD34+ cells (1.5–3.4%11) and especially low NBC numbers in the transplant it is furthermore necessary to apply sensitive tumour cell analysis methods such as quantitative RT-PCR to analyse clinically relevant samples, which will be addressed in future studies.